This Article Abstract Full Text (PDF) All Versions of this Article: 108/23/2905    most recent 01.CIR.0000101921.93016.1Cv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shishido, T. Articles by Kubota, I. Search for Related Content PubMed PubMed Citation Articles by Shishido, T. Articles by Kubota, I. Related Collections Remodeling

(Circulation. 2003;108:2905.)
© 2003 American Heart Association, Inc.

Basic Science Reports

Toll-Like Receptor-2 Modulates Ventricular Remodeling After Myocardial Infarction

Tetsuro Shishido, MD; Naoki Nozaki, MD, PhD; Seiji Yamaguchi, MD, PhD; Yoko Shibata, MD, PhD; Joji Nitobe, MD, PhD; Takuya Miyamoto, MD; Hiroki Takahashi, MD; Takanori Arimoto, MD; Kunihiko Maeda, MD, PhD; Mitsunori Yamakawa, MD, PhD; Osamu Takeuchi, MD, PhD; Shizuo Akira, MD, PhD; Yasuchika Takeishi, MD, PhD; Isao Kubota, MD, PhD

From the First Department of Internal Medicine (T.S., N.N., Y.S., J.N., T.M., H.T., T.A., Y.T., I.K.) and First Department of Pathology (K.M., M.Y.), Yamagata University School of Medicine, Yamagata; Sagae City Hospital, Sagae (S.Y.); and Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka (O.T., S.A.), Japan.

Correspondence to Yasuchika Takeishi, MD, PhD, First Department of Internal Medicine, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, Japan 990-9585. E-mail takeishi{at}med.id.yamagata-u.ac.jp

Received December 18, 2002; de novo received June 11, 2003; revision received August 7, 2003; accepted August 8, 2003.

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Background— Toll-like receptors (TLRs) are members of the interleukin-1 receptor family and transduce similar signals as interleukin-1 receptor in response to exogenous pathogens. Recent studies have demonstrated that TLRs are activated by endogenous signals, such as heat shock proteins and oxidative stress, that may contribute to ventricular remodeling after myocardial infarction. In this study, we determined whether TLR-2 was involved in cardiac remodeling after myocardial infarction.

Methods and Results— Myocardial infarction was induced by surgical left anterior descending coronary artery ligation on wild-type (WT) mice and TLR-2–knockout (KO) mice. The survival rate was significantly higher in KO mice than in WT mice 4 weeks after myocardial infarction (65% versus 43%, P<0.03). Infarct size and degree of inflammatory cell infiltration in infarct area were similar between WT and KO mice. However, myocardial fibrosis in the noninfarct area of KO mice was much less than in WT mice (P<0.01) and was accompanied by reduced transforming growth factor-ß₁ and collagen type 1 mRNA expressions (P<0.01 and P<0.05, respectively). Left ventricular dimensions at end diastole were smaller in KO mice than in WT mice at 1 week (P<0.05) and 4 weeks (P<0.01) after surgery. Furthermore, fractional shortening was higher (27.7±2.5% versus 21.2±2.6%, P<0.05, at 1 week, and 24.3±2.0% versus 16.6±2.5%, P<0.01, at 4 weeks) in KO mice compared with WT mice.

Conclusions— These data suggest that TLR-2 plays an important role in ventricular remodeling after myocardial infarction.

Key Words: receptors • remodeling • myocardial infarction • heart failure

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
Toll-like receptors (TLRs) recognize exogenous ligands, such as lipopolysaccharide, peptidoglycan, bacterial lipoprotein, and oligonucleotides, during the inflammatory responses.^1,2 TLRs have interleukin-1 receptor–like intracellular signaling pathways that lead to nuclear localization of nuclear factor (NF)-B/Rel-type transcription factors.^1–3 Furthermore, TLRs are expressed in various organs, such as lung, brain, kidney, and heart.^2,4 In vitro studies using isolated cardiomyocytes and in vivo studies using C3H/HeJ mice, which are TLR-4 deficient, have suggested that myocardial activated TLR-mediated signaling pathways in response to exogenous ligands induce cardiac dysfunction.^5–7 Recent studies have demonstrated that TLR-mediated signaling pathways are also activated by endogenous ligands, such as heat-shock protein and oxidative stress, in isolated ventricular cardiomyocytes.^8,9

A large myocardial infarction induces ventricular remodeling, which contributes to cardiac dysfunction and mortality.^10,11 The ventricular remodeling process involves several mediators, such as oxidative stress,¹² cytokines,¹³ and neurohormones.¹⁴ Several lines of evidence have suggested that oxidative stress alters cell survival and hypertrophic signals that lead to cardiomyocyte apoptosis and/or hypertrophy in isolated cardiomyocytes and in animals.^12,15–18

Because oxidative stress after myocardial infarction was identified as playing a pivotal role for ventricular remodeling, we hypothesized that TLR-2 deficiency resulted in derangement of ventricular remodeling and preservation in cardiac function after myocardial infarction. To evaluate the potential role of TLR-2 on ventricular remodeling after myocardial infarction, we examined the effects of TLR-2 deficiency on cardiac function, structural aspects of ventricular remodeling, and survival rates after myocardial infarction in a mouse model.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
Animals
Male TLR-2–knockout (KO) mice and wild-type (WT) mice with the same C57BL/6 backgrounds were used. Mice were housed in a facility with a 12/12-hour light/dark cycle and were given free access to water and standard rodent chow. The room was kept specific pathogen–free. The animals were handled according to the animal welfare regulations of Yamagata University, and the study protocol was approved by the Animal Subjects Committee of Yamagata University. The investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.

Left Coronary Artery Ligation
Induction of myocardial infarction was performed as described previously,^14,16 with minor modifications. Briefly, mice (25 to 35 g body weight) were anesthetized by intraperitoneal injection with a mixture of ketamine (80 mg/kg) and xylazine (8 mg/kg). Animals were intubated with a 20-gauge polyethylene catheter and were ventilated with a rodent ventilator (Harvard Apparatus). A median sternotomy was performed, the left anterior descending artery was identified, and a 7-0 proline suture was passed around the artery and subsequently tied off. Infarction was evident from discoloration of the left ventricle (LV). Finally, the chest wall was closed. The animals remained in a supervised setting until fully conscious.

Echocardiography
Transthoracic echocardiography was performed as described previously⁶ with a FFsonic 8900 (Fukuda Denshi) with a 10-MHz phased-array transducer at 1 or 4 weeks after surgery. LV internal dimensions at end systole and end diastole (LVESD and LVEDD) were measured digitally on the M-mode tracings and averaged from 3 cardiac cycles.^14,16 LV fractional shortening (%FS) was calculated as [(LVEDD-LVESD)/LVEDD]x100.

Morphological Examination and Infarct Size Measurement
At 3 days, 1 week, and 4 weeks after surgery, the heart was excised and fixed with a 10% solution of formalin in PBS. The heart was embedded in paraffin and cut serially from the apex to the base. The infarct size was expressed as a percentage of the total LV wall circumference from each of the 3 LV sections.¹⁶

To assess polymorphonuclear neutrophil infiltration, the sections stained with hematoxylin and eosin were observed microscopically, and the numbers of polymorphonuclear neutrophils were counted in 3 to 5 fields for each heart.¹⁷

To assess the degree of fibrosis in the noninfarct area, the sections were stained with Azan-Mallory stain. In each section, high-power fields at a magnification of x400 were scanned with computer-assisted videodensitometry, and the images from at least 10 fields for each heart were analyzed as described previously.¹² The collagen volume fraction was obtained by calculating the mean ratio of Azan-Mallory–stained connective tissue to the total myocardial area. We also traced the outline of 100 myocytes in each section, and myocyte cross-sectional area was measured.

Immunohistochemistry
The sections embedded in paraffin were incubated with primary antibody specific to activated macrophages (Mac-3 monoclonal antibody, BD Pharmingen) for 16 hours, followed by biotinylated secondary antibody (biotinylated anti-rat antibody, Jackson ImmunoResearch Laboratories, Inc) and then by avidin-conjugated horseradish peroxidase. Color development was performed with 3,3'-diaminobenzidine, and slides were counterstained with hematoxylin.¹⁹ The degree of macrophage emigration was expressed as a percentage of Mac-3–positive cells to total nucleated cells in infarct area.

Extraction of Total RNAs and Reverse Transcriptase–Polymerase Chain Reaction
Total RNAs were extracted from noninfarct LV using TRIzol (Invitrogen, Tokyo, Japan) and subjected to reverse transcriptase reverse transcriptase–polymerase chain reaction (RT-PCR) amplification using oligonucleotide primers.¹⁹ PCR primers for transforming growth factor-ß₁ (TGF-ß₁) were 5'-ACCGCAACAACG-CCATCTAT-3' (forward) and 5'-GTAACGCCAGGAATT-GTTGC-3' (reverse), primers for collagen type 1 were 5'-GTGAACCTGGCAAACAAGGT-3' (forward) and 5'-CTG-GAGACCAGAGAAGCCAC-3' (reverse), and primers for GAPDH were 5'-ACTCCACTCACGGCAAATTCAACGG-3' (forward) and 5'-AGGGGCGGAGATGATGACCC-3' (reverse).¹⁹ The PCR products were fractionated on a 1% to 2% agarose gel and visualized by ethidium bromide staining. The intensities of the bands were normalized for GAPDH and were expressed as fold increase over control WT.

Statistical Analysis
All values are expressed as mean±SEM. Comparisons of the histological analysis between WT and KO mice were made by Student’s unpaired t test. To compare body weight, LV weight, lung weight, LVEDD, LVESD, %FS, and RT-PCR data, 1-way ANOVA followed by post hoc test was performed. Survival curves after myocardial infarction were created by the Kaplan-Meier method and compared by log-lank test. Statistical significance was accepted at a value of P<0.05.

	Results

Top Abstract Introduction Methods Results Discussion References

 
Heart Failure and Ventricular Remodeling After Myocardial Infarction
There were no differences in body weight among 4 groups before and after myocardial infarction. Heart weight and LV weight after myocardial infarction were lower in KO mice than in WT mice (Table). Furthermore, lung weight was also lower in KO mice than in WT mice (Table).

View this table: [in this window] [in a new window]   Weight Parameters

Survival Rates and Infarct Size
The survival rates after myocardial infarction were compared up to 4 weeks between WT (n=107) and KO (n=80) mice, as shown in Figure 1. The rate of death during surgery was not different between WT and KO mice (14% and 15%, respectively). The survival rate up to 4 weeks after myocardial infarction was significantly higher in KO mice than in WT mice (65% versus 43%, P<0.03). However, infarct size at 4 weeks after coronary ligation was similar between WT and KO mice, as shown in Figure 2 (55.6±4.2% and 53.2±3.7%, respectively).

View larger version (13K): [in this window] [in a new window]   Figure 1. Survival curves after myocardial infarction in WT and KO mice. Survival curves were created by Kaplan-Meier method and compared by log-lank test. Percentages of surviving WT and KO mice were plotted. At 4 weeks after myocardial infarction, survival rates were significantly higher in KO mice than in WT mice.

View larger version (98K): [in this window] [in a new window]   Figure 2. Histological analysis of infarct area after myocardial infarction. Top and bottom, Azan-Mallory–stained LV transverse sections in WT and KO mice, respectively.

Assessment of Inflammatory Cell Infiltration Into the Infarct Area
At 3 days and 1 week after myocardial infarction, histological sections of the infarcted area were evaluated to assess the degree of accumulated polymorphonuclear neutrophils and macrophages, because it has been reported that these are important sources for chemokine and cytokine induction or production.²⁰ After myocardial infarction, polymorphonuclear neutrophils and activated Mac-3–positive macrophages were infiltrated into the infarct area in WT and KO mice (data not shown). However, morphometric analysis demonstrated that there was no significant difference in the degree of inflammatory cell infiltration between WT and KO mice.

The numbers of polymorphonuclear neutrophil infiltration (per 10⁴ µm²) were 41.2±3.5 and 41.0±2.9 at 3 days after myocardial infarction and 54.3±2.8 and 55.0±3.3 at 1 week after myocardial infarction in WT and KO mice, respectively. The degrees of Mac-3–positive macrophage infiltration were 41.0±4.0% and 41.1±3.4% at 3 days and 45.1±4.0% and 44.2±3.3% at 1 week after myocardial infarction in WT and KO mice, respectively.

Echocardiographic Measurements
Echocardiography was performed at baseline control and at 1 or 4 weeks after myocardial infarction in WT and KO mice. Under anesthesia, the heart rate was similar between WT and KO mice at each point (data not shown). The representative M-mode echocardiograms of WT and KO mice at baseline and 1 and 4 weeks after myocardial infarction are shown in Figure 3. Before coronary ligation, LVEDD, LVESD, and %FS were similar between WT and KO mice (baseline). LV dilatation after myocardial infarction was evident in both WT and KO mice; however, KO mice showed less ventricular dilatation. LVEDD and LVESD were smaller in KO mice than in WT mice at 1 and 4 weeks after operation, as shown in Figure 4, A and B. LVEDDs (mm) were 4.18±0.11 (n=13) and 4.61±0.17 (n=12) at 1 week (P<0.05) and 4.64±0.13 (n=15) and 5.13±0.16 (n=13) at 4 weeks (P<0.01) in KO mice and WT mice, respectively. LVESDs (mm) were 3.04±0.15 and 3.74±0.19 (P<0.05) at 1 week and 3.53±0.16 and 4.30±0.23 (P<0.01) at 4 weeks in KO mice and WT mice, respectively. Moreover, %FS was significantly higher at 1 and 4 weeks after surgery in KO mice than in WT mice, as shown in Figure 4C (27.7±2.5% versus 21.2±2.6%, P<0.05, at 1 week and 24.3±2.0% versus 16.6±2.5%, P<0.01, at 4 weeks). Both WT and KO mice showed linear relationships (r=0.68 and r=0.62, respectively, P<0.05) between infarct size and %FS at 4 weeks (Figure 4D).

View larger version (61K): [in this window] [in a new window]   Figure 3. Representative M-mode traces in WT mice (A, C, and E) and KO mice (B, D, and F) at baseline, 1 week, and 4 weeks after myocardial infarction, respectively. AW, PW, and LVD indicate anterior wall, posterior wall, and LV internal dimension, respectively. After myocardial infarction, LVD was increased in both animals; however, LVEDD and LVESD at 4 weeks after myocardial infarction in KO mice were clearly smaller than in WT mice.

View larger version (23K): [in this window] [in a new window]   Figure 4. Quantified data for echocardiographic measurements. A through C, LVEDD and LVESD at 4 weeks after myocardial infarction in KO mice were reduced significantly, by 9.6% and 18.0%, respectively, compared with WT mice. All data were obtained from 12 to 15 animals in each group. Although %FS was reduced in both WT and KO mice after myocardial infarction, %FS in KO mice was significantly higher than that in WT mice. D, Both WT mice (n=12) and KO mice (n=10) showed linear relationships (r=0.68 and r=0.62, respectively, P<0.05) between infarct size and %FS. At baseline, LVEDD, LVESD, and %FS in WT mice (WT-con) and KO mice (KO-con) were similar. *P<0.05 and **P<0.01 vs WT at each time point; P<0.01 vs control in same strain. 1w and 4w indicate 1 week and 4 weeks after myocardial infarction, respectively. Open symbols and filled symbols indicate WT and KO mice, respectively.

Assessment of Myocardial Fibrosis in Noninfarct Area
Morphological changes at the noninfarct area were similar between WT and KO mice at 3 days after myocardial infarction (data not shown). At 1 and 4 weeks after surgery, cardiomyocytes showed mild architectural alteration in KO mice compared with WT mice (data not shown). Myocyte cross-sectional area was not different between KO mice (331.2±48.8 µm²) and WT mice (407.6±66.2 µm²). In KO mice, the degrees of myocardial fibrosis at the noninfarcted interstitial area (0.34±0.06 versus 1.00±0.22, P<0.01) and perivascular area (0.35±0.04 versus 1.00±0.17, P<0.01) were much less than in WT mice at 4 weeks after myocardial infarction (Figure 5, A–E).

View larger version (68K): [in this window] [in a new window]   Figure 5. Histological changes in noninfarct area at 4 weeks after myocardial infarction in WT and KO mice. A through D, Azan-Mallory–stained sections in noninfarct area. A and B demonstrate interstitial, and C and D perivascular, sections. E, In KO mice, myocardial fibrosis in interstitial and perivascular areas at 4 weeks after myocardial infarction were attenuated compared with WT mice.

To investigate whether these morphological observations were accompanied by alterations in gene expression relevant to fibrotic changes, we measured mRNA levels of TGF-ß₁ and collagen type 1 at 1 week after myocardial infarction. RT-PCR revealed that TGF-ß₁ and collagen type 1 mRNA obtained from noninfarcted myocardium at 1 week after myocardial infarction were upregulated after myocardial infarction in both WT and KO mice. However, these changes in TGF-ß₁ and collagen type 1 mRNA expressions after myocardial infarction were attenuated in KO mice compared with WT mice, as shown in Figure 6A. When normalized for GAPDH mRNA, the expressions of TGF-ß₁ and collagen type 1 in KO mice were reduced by 34.2% (P<0.01) and 38.6% (P<0.05), respectively, compared with WT mice (Figure 6B).

View larger version (33K): [in this window] [in a new window]   Figure 6. Quantification of gene expression related to fibrotic changes. A, RT-PCR was performed to evaluate TGF-ß1 and collagen type 1 mRNA expression after myocardial infarction. B, Group data for relative band intensity of TGF-ß1, collagen type 1, and GAPDH. At baseline, TGF-ß1 and collagen type 1 mRNA expressions were similar between WT (WT-con) and KO (KO-con) mice. At 1 week after myocardial infarction, myocardial expressions of TGF-ß1 and collagen type 1 mRNA were increased in WT (WT-MI) and KO (KO-MI) mice. However, induced gene expressions were attenuated in KO mice compared with WT mice. All data are expressed as mean±SEM. *P<0.05 and **P<0.01 vs WT at each time point. P<0.05 and P<0.01 vs control in same strain.

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
In the present study, we examined whether ventricular remodeling after myocardial infarction was altered in TLR-2–KO mice. TLR-2–KO mice demonstrated higher survival rate and less ventricular remodeling evaluated by echocardiography, associated with fewer pathological changes and decreased expression of TGF-ß₁ and collagen type 1 mRNA. The present study provided the direct evidence for involvement of TLR-2–mediated signaling pathway in ventricular remodeling after myocardial infarction.

Previous studies have documented that TLRs are expressed in many organs, such as spleen, brain, kidney, liver, lung, and heart, and act differentially in a wider pattern of tissue expression.^2,4,21 In an in vivo study, Nemoto et al⁷ demonstrated that myocardial TLRs are involved in cardiac dysfunction during inflammatory shock. However, the potential role of TLR-2 in ventricular remodeling after myocardial infarction is still unknown. In this study, at 1 and 4 weeks after myocardial infarction, LVEDD and LVESD were smaller in TLR-2–KO mice than in WT mice. Furthermore, %FS was markedly higher in TLR-2–KO mice than WT mice, which was associated with a better survival rate in KO mice. These results suggest that TLR-2 plays an important role in ventricular remodeling after myocardial infarction.

Several studies have demonstrated that myocardial infarction is associated with inflammatory responses, which can extend myocardial injury.²⁰ Reduced numbers of neutrophils by antineutrophil drugs¹⁷ or neutrophil filters²² can reduce myocardial injury after ischemia. Furthermore, Li et al²³ demonstrated that necrotic cells activate NF-B in macrophages and induce expression of genes involved in inflammatory response through TLR-2–mediated signaling pathways. In our present study, activated macrophages stained with anti–Mac-3 antibody²⁴ and polymorphonuclear neutrophil accumulation infiltrated into the infarct area were unexpectedly similar between WT and TLR-2–KO mice at 3 days and 1 week after myocardial infarction. However, we did not exclude the possibility for attenuated activity of inflammatory cells in TLR-2–KO mice.

TLR-2 is known to recognize exogenous ligands in response to such pathogens as oligonucleotides and bacterial lipoprotein from gram-positive bacteria.^1–3 Although several studies have demonstrated that neurohormones modulate ventricular remodeling,¹² TLR-2 has an interleukin-1 receptor–like intracellular signaling domain, and there is no evidence that TLR-mediated signaling pathways are activated by such factors. It has been demonstrated that before injection of lipopolysaccharide, hemodynamic and echocardiographic parameters are similar between TLR-4–deficient and WT mice.⁷ In the present study, there was no difference in cardiac function at baseline between WT and KO mice.

Accumulating evidence has reported that oxidative stress contributes to ventricular remodeling after myocardial infarction.^12,15–18 Frantz et al⁹ demonstrated that endogenous ligands, such as oxidative stress, upregulate NF-B DNA binding activity through the TLR-2–mediated signaling pathway in cardiomyocytes and Chinese hamster ovary fibroblasts. In this study, cardiac dysfunction evaluated by echocardiography at 4 weeks after myocardial infarction was abrogated in TLR-2–KO mice compared with WT mice. Therefore, ventricular remodeling after myocardial infarction was modulated through TLR-2.

In this study, histological examinations demonstrated that myocardial fibrosis was decreased significantly in KO mice at noninfarct area. Furthermore, gene expressions of TGF-ß₁ and collagen type 1, which were responsible for cardiac fibrosis,^12,25 were lower in KO mice than WT mice after myocardial infarction. These data support the concept that modulation of myocardial fibrosis in the noninfarct area is one of the possible mechanisms for attenuation of ventricular remodeling in TLR-2–KO mice.

We reported the preservation of cardiac function, increased survival rate, and attenuation of myocardial fibrosis after myocardial infarction in TLR-2–KO mice. In conclusion, this study demonstrates the first evidence that ventricular remodeling after myocardial infarction occurs, at least in part, through the TLR-2–mediated pathway. These results will allow us a novel approach to investigate the pathogenesis of ventricular remodeling after myocardial infarction.

	Acknowledgments

 
This study was supported in part by grants-in-aid for Scientific Research (14770306 to Dr Nozaki and 14570635 to Dr Takeishi) from the Ministry of Education, Science, Sports, and Culture, Japan, and grants from the Naito Foundation, the Japanese Heart Foundation, and the Japan Foundation for Cardiovascular Research. We thank Eiji Tsuchida and Yukiko Takahashi for their excellent technical assistance.

	References

Top Abstract Introduction Methods Results Discussion References

 
1. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001; 2: 675–680.[CrossRef][Medline] [Order article via Infotrieve]

2. Schuster JM, Nelson PS. Toll receptors: an expanding role in our understanding of human disease. J Leukoc Biol. 2000; 67: 767–773.[Abstract]

3. Burns K, Martinon F, Esslinger C, et al. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem. 1998; 273: 12203–12209.[Abstract/Free Full Text]

4. Rock FL, Hardiman G, Timans JC, et al. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A. 1998; 95: 588–593.[Abstract/Free Full Text]

5. Frantz S, Kobzik L, Kim YD, et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest. 1999; 104: 271–280.[Medline] [Order article via Infotrieve]

6. Baumgarten G, Knuefermann P, Nozaki N, et al. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. J Infect Dis. 2001; 183: 1617–1624.[CrossRef][Medline] [Order article via Infotrieve]

7. Nemoto S, Vallejo JG, Knuefermann P, et al. Escherichia coli LPS–induced LV dysfunction: role of toll-like receptor-4 in the adult heart. Am J Physiol. 2002; 282: H2316–H2323.

8. Ohashi K, Burkart V, Flohe S, et al. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol. 2000; 164: 558–561.[Abstract/Free Full Text]

9. Frantz S, Kelly RA, Bourcier T. Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J Biol Chem. 2001; 276: 5197–5203.[Abstract/Free Full Text]

10. Pfeffer JM, Pfeffer MA, Fletcher PJ, et al. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol. 1991; 260: H1406–H1414.[Medline] [Order article via Infotrieve]

11. Abbate A, Bussani R, Biondi-Zoccai GG, et al. Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction. Circulation. 2002; 106: 1051–1054.[Abstract/Free Full Text]

12. Takeishi Y, Jalili T, Ball NA, et al. Responses of cardiac protein kinase C isoforms to distinct pathological stimuli are differentially regulated. Circ Res. 1999; 85: 264–271.[Abstract/Free Full Text]

13. Okuyama M, Yamaguchi S, Nozaki N, et al. Serum levels of soluble form of Fas molecule in patients with congestive heart failure. Am J Cardiol. 1997; 79: 1698–1701.[CrossRef][Medline] [Order article via Infotrieve]

14. Harada K, Sugaya T, Murakami K, et al. Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation. 1999; 100: 2093–2099.[Abstract/Free Full Text]

15. Yamaoka M, Yamaguchi S, Suzuki T, et al. Apoptosis in rat cardiac myocytes induced by Fas ligand: priming for Fas-mediated apoptosis with doxorubicin. J Mol Cell Cardiol. 2000; 32: 881–889.[CrossRef][Medline] [Order article via Infotrieve]

16. Gao XM, Dart AM, Dewar E, et al. Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice. Cardiovasc Res. 2000; 45: 330–338.[Abstract/Free Full Text]

17. Hoffmeyer MR, Scalia R, Ross CR, et al. PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia-reperfusion injury in mice. Am J Physiol. 2000; 279: H2824–H2828.

18. Hwang MW, Matsumori A, Furukawa Y, et al. Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. J Am Coll Cardiol. 2001; 38: 1546–1553.[Abstract/Free Full Text]

19. Shibata Y, Zsengeller Z, Otake K, et al. Alveolar macrophage deficiency in osteopetrotic mice deficient in macrophage colony-stimulating factor is spontaneously corrected with age and associated with matrix metalloproteinase expression and emphysema. Blood. 2001; 98: 2845–2852.[Abstract/Free Full Text]

20. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002; 53: 31–47.[Abstract/Free Full Text]

21. Aliprantis AO, Yang RB, Weiss DS, et al. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 2000; 19: 3325–3336.[CrossRef][Medline] [Order article via Infotrieve]

22. Engler RL, Dahlgren MD, Morris DD, et al. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol. 1986; 251: H314–H323.[Medline] [Order article via Infotrieve]

23. Li M, Carpio DF, Zheng Y, et al. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol. 2001; 166: 7128–7135.[Abstract/Free Full Text]

24. Flotte TJ, Springer TA, Thorbecke GJ. Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets. Am J Pathol. 1983; 111: 112–124.[Abstract]

25. Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis. Circ Res. 2002; 91: 1103–1113.[Abstract/Free Full Text]

This article has been cited by other articles:

				Q. Yu, R. Vazquez, E. V. Khojeini, C. Patel, R. Venkataramani, and D. F. Larson IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H76 - H85. [Abstract] [Full Text] [PDF]

				L. Timmers and D. P.V. de Kleijn Response to the Letter by Frantz and Bauersachs Circ. Res., June 5, 2009; 104(11): e61 - e61. [Full Text] [PDF]

				G. Valen Extracardiac approaches to protecting the heart Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 651 - 657. [Abstract] [Full Text] [PDF]

				L. Timmers, J. K. van Keulen, I. E. Hoefer, M. F.L. Meijs, B. van Middelaar, K. den Ouden, C. J.A. van Echteld, G. Pasterkamp, and D. P.V. de Kleijn Targeted Deletion of Nuclear Factor {kappa}B p50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction Circ. Res., March 13, 2009; 104(5): 699 - 706. [Abstract] [Full Text] [PDF]

				S. Frantz, J. Bauersachs, and G. Ertl Post-infarct remodelling: contribution of wound healing and inflammation Cardiovasc Res, February 15, 2009; 81(3): 474 - 481. [Abstract] [Full Text] [PDF]

				U. Landmesser, K. C. Wollert, and H. Drexler Potential novel pharmacological therapies for myocardial remodelling Cardiovasc Res, February 15, 2009; 81(3): 519 - 527. [Abstract] [Full Text] [PDF]

				P. Dandona, A. Chaudhuri, H. Ghanim, and P. Mohanty Insulin as an anti-inflammatory and antiatherogenic modulator. J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S14 - S20. [Abstract] [Full Text] [PDF]

				W. Chao Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H1 - H12. [Abstract] [Full Text] [PDF]

				T. Kitahara, Y. Takeishi, M. Harada, T. Niizeki, S. Suzuki, T. Sasaki, M. Ishino, O. Bilim, O. Nakajima, and I. Kubota High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice Cardiovasc Res, July 7, 2008; (2008) cvn163v2. [Abstract] [Full Text] [PDF]

				T. Shishido, C.-H. Woo, B. Ding, C. McClain, C. A. Molina, C. Yan, J. Yang, and J.-i. Abe Effects of MEK5/ERK5 Association on Small Ubiquitin-Related Modification of ERK5: Implications for Diabetic Ventricular Dysfunction After Myocardial Infarction Circ. Res., June 6, 2008; 102(11): 1416 - 1425. [Abstract] [Full Text] [PDF]

				A. Yoshizaki, Y. Iwata, K. Komura, F. Ogawa, T. Hara, E. Muroi, M. Takenaka, K. Shimizu, M. Hasegawa, M. Fujimoto, et al. CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced Scleroderma Am. J. Pathol., June 1, 2008; 172(6): 1650 - 1663. [Abstract] [Full Text] [PDF]

				A. Riad, S. Jager, M. Sobirey, F. Escher, A. Yaulema-Riss, D. Westermann, A. Karatas, M. M. Heimesaat, S. Bereswill, D. Dragun, et al. Toll-Like Receptor-4 Modulates Survival by Induction of Left Ventricular Remodeling after Myocardial Infarction in Mice J. Immunol., May 15, 2008; 180(10): 6954 - 6961. [Abstract] [Full Text] [PDF]

				S.-C. Tang, T. V. Arumugam, X. Xu, A. Cheng, M. R. Mughal, D. G. Jo, J. D. Lathia, D. A. Siler, S. Chigurupati, X. Ouyang, et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits PNAS, August 21, 2007; 104(34): 13798 - 13803. [Abstract] [Full Text] [PDF]

				J. Favre, P. Musette, V. Douin-Echinard, K. Laude, J.-P. Henry, J.-F. Arnal, C. Thuillez, and V. Richard Toll-Like Receptors 2-Deficient Mice Are Protected Against Postischemic Coronary Endothelial Dysfunction Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1064 - 1071. [Abstract] [Full Text] [PDF]

				A. Linde, D. Mosier, F. Blecha, and T. Melgarejo Innate immunity and inflammation - New frontiers in comparative cardiovascular pathology Cardiovasc Res, January 1, 2007; 73(1): 26 - 36. [Abstract] [Full Text] [PDF]

				A. A. Babcock, M. Wirenfeldt, T. Holm, H. H. Nielsen, L. Dissing-Olesen, H. Toft-Hansen, J. M. Millward, R. Landmann, S. Rivest, B. Finsen, et al. Toll-Like Receptor 2 Signaling in Response to Brain Injury: An Innate Bridge to Neuroinflammation J. Neurosci., December 6, 2006; 26(49): 12826 - 12837. [Abstract] [Full Text] [PDF]

				L. Romics Jr, G. Szabo, J. C. Coffey, J. H. Wang, and H. P. Redmond The Emerging Role of Toll-Like Receptor Pathways in Surgical Diseases Arch Surg, June 1, 2006; 141(6): 595 - 601. [Abstract] [Full Text] [PDF]

				T. Arimoto, Y. Takeishi, H. Takahashi, T. Shishido, T. Niizeki, Y. Koyama, R. Shiga, N. Nozaki, O. Nakajima, K. Nishimaru, et al. Cardiac-Specific Overexpression of Diacylglycerol Kinase {zeta} Prevents Gq Protein-Coupled Receptor Agonist-Induced Cardiac Hypertrophy in Transgenic Mice Circulation, January 3, 2006; 113(1): 60 - 66. [Abstract] [Full Text] [PDF]

				R. J. van Oort and L. J. De Windt TOLL-erating cardiac hypertrophy following pressure overload Cardiovasc Res, November 1, 2005; 68(2): 178 - 179. [Full Text] [PDF]

				H. Takahashi, Y. Takeishi, T. Seidler, T. Arimoto, H. Akiyama, Y. Hozumi, Y. Koyama, T. Shishido, Y. Tsunoda, T. Niizeki, et al. Adenovirus-Mediated Overexpression of Diacylglycerol Kinase-{zeta} Inhibits Endothelin-1-Induced Cardiomyocyte Hypertrophy Circulation, March 29, 2005; 111(12): 1510 - 1516. [Abstract] [Full Text] [PDF]

				P. Tobias and L. K. Curtiss Thematic review series: The Immune System and Atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis J. Lipid Res., March 1, 2005; 46(3): 404 - 411. [Abstract] [Full Text] [PDF]

				Y. Zhai, X.-d. Shen, R. O'Connell, F. Gao, C. Lassman, R. W. Busuttil, G. Cheng, and J. W. Kupiec-Weglinski Cutting Edge: TLR4 Activation Mediates Liver Ischemia/Reperfusion Inflammatory Response via IFN Regulatory Factor 3-Dependent MyD88-Independent Pathway J. Immunol., December 15, 2004; 173(12): 7115 - 7119. [Abstract] [Full Text] [PDF]

				N. Nozaki, T. Shishido, Y. Takeishi, and I. Kubota Modulation of Doxorubicin-Induced Cardiac Dysfunction in Toll-Like Receptor-2-Knockout Mice Circulation, November 2, 2004; 110(18): 2869 - 2874. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 108/23/2905    most recent 01.CIR.0000101921.93016.1Cv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shishido, T. Articles by Kubota, I. Search for Related Content PubMed PubMed Citation Articles by Shishido, T. Articles by Kubota, I. Related Collections Remodeling